Developer docs
API playgroundTry for free, no card

Search company profiles

REV Clinical

Full company profile

uuid0009tmt

Namestring
REV Clinical
Legal namestring
REV Clinical
Websiteurl
revclinical.com
Company typeenum
Private
Founded yearint
2010
Descriptiontext

REV Clinical is a US-headquartered contract research organization (CRO) founded in 2010 as CBCC Global Research and rebranded under its current name in January 2026. The company provides end-to-end clinical trial services for pharmaceutical, biotechnology, and medical-device sponsors, organized around six solution lines: Clinical Trial Design & Operations, Regulatory & Submission Expertise, Biometrics & Data Management, the proprietary Global Velocity Network™, Quality & Compliance, and Trial Rescue Services. Therapeutic specialization covers oncology, neurology, ophthalmology, and rare disease, with claimed depth in 17+ oncology indications and experience across first-in-human through pivotal and post-market studies.

The operational backbone is the Global Velocity Network™, a tri-country site and operational footprint concentrated in the United States (Bakersfield, CA headquarters), India (Ahmedabad subsidiary, acquired in 2012 from Vibgyor Scientific Research), and Australia (Melbourne office opened May 2026). The company reports partnerships with 500+ clinical sites, access to approximately 4,000 new oncology patients annually via the affiliated CBCC Oncology Center, 50+ regulatory inspections cleared since 2021 without material findings (FDA, EMA, ANVISA, ISO, CDSCO, MOH Kazakhstan), and a Track record of 15+ trial rescue engagements with >80% of rescued trials exceeding patient-recruitment targets.

REV Clinical generates revenue through fee-for-service, project-based clinical trial contracts priced by scope, phase, therapeutic area, and geographic reach, with multi-year contract cadences. Go-to-market is direct enterprise sales led by senior leadership engagement, supplemented by participation in industry conferences (ASRS, AAO, CPHI Milan, ASH, CNS Summit) and content marketing through its Knowledge Center. The company is privately held following a 2025 partnership with Edgewater Capital Partners, and employs 200+ professionals globally (with a separate firmographic count of 51-100 reported W-2 employees).

Short descriptiontext

REV Clinical is a US-based clinical CRO providing end-to-end trial design, regulatory, biometrics, and rescue services for pharmaceutical, biotech, and medtech sponsors, with operational hubs in the US, India, and Australia via its Global Velocity Network™.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersBakersfield, United States
HQ citystring
Bakersfield
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical research services, contract research organization, clinical trial management, regulatory submission services, biometrics data management
Industry4 codes
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLAGAAAF
Clinical Data Management, Biostatistics & Statistical Programming CROs
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Contract Research Organization (CRO) / Clinical Research Services
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Trial Services
TypeProfessional Services
Description

REV Clinical operates as a Contract Research Organization (CRO) providing fee-for-service clinical trial services including trial design, regulatory submissions, biometrics, site management, and operational execution. Services are provided to pharmaceutical, biotech, and medtech sponsors on a project-by-project basis with pricing based on scope, phase, and geographic reach.

revclinical.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Custom project-based pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing is quote-based and determined by project scope, phase, therapeutic area, and geographic requirements. No standard pricing tiers are publicly disclosed.

revclinical.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

REV Clinical is a US-based Contract Research Organization (CRO) that designs, manages, and executes clinical trials for pharmaceutical, biotech, and medtech sponsors. The company provides end-to-end services including clinical trial design and operations, regulatory submissions, biometrics and data management, quality compliance, and trial rescue services. It operates a proprietary Global Velocity Network™ of strategic sites across the United States, India, and Australia, with deep therapeutic expertise in oncology, neurology, ophthalmology, and rare disease.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Exceeds patient recruitment targets for >80% of rescue trials
+2 more records
Product overview1 text field

REV Clinical is a US-based clinical CRO providing a comprehensive suite of integrated clinical research services organized around six core offerings: Clinical Trial Design & Operations, Regulatory & Submission Expertise, Biometrics & Data Management, the Global Velocity Network™ (strategic site network across US, India, and Australia), Quality & Compliance, and Trial Rescue Services. The company specializes in four therapeutic areas: Oncology, Neurology, Ophthalmology, and Rare Disease. The Global Velocity Network™ serves as the operational backbone connecting site networks across strategic hub regions, while Quality & Compliance underpins all services through rigorous SOPs and regulatory compliance. The Trial Rescue Services offering extends the company's value proposition to troubled trials requiring rapid intervention.

Product and service1 record
1Clinical Trial Design & Operations
Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic alliance with CBCC Oncology Center in Bakersfield, California provides access to world-class clinicians, facilities, and equipment, as well as approximately 4,000 new oncology patients annually. The center provides end-to-end care including screening, biospecimen collection/testing, imaging, infusions, injections, and surgeries within a 150,000-square-foot complex staffed by over 360 specialists. This partnership accelerates enrollment in REV's oncology trials conducted in the US.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Mid-sized clinical CRO with concentrated therapeutic expertise (oncology, neurology, rare disease) and a reputation for operational rigor; competes head-to-head with REV for biotech and mid-cap pharma trials.

TypeDirect peer
Description

Mid-sized specialty CRO with strong neuroscience and oncology focus serving small to mid-sized biotech; closely comparable business model and target customer to REV Clinical.

TypeDirect peer
Description

Specialty CRO with deep pediatric, oncology, and rare disease focus; competes directly with REV for niche clinical trial programs from emerging biotech sponsors.

TypeDirect peer
Description

Mid-sized full-service CRO emphasizing flexible, mid-tier biotech client engagement with therapeutic breadth including oncology; comparable customer profile and operational model to REV.

TypeEmerging player
Description

Asia-Pacific-headquartered CRO known for biotech-focused clinical trial services across the region; relevant as a regional capability comparator for REV's Global Velocity Network including its new Australia hub.

TypeBroad incumbent
Description

Largest global CRO and clinical services provider; competes broadly with REV in oncology and other therapeutic areas but at vastly greater scale and technology depth.

TypeBroad incumbent
Description

Top-tier global CRO with full-service clinical development capabilities; competing incumbent for the same pharma and biotech budgets as REV.

TypeBroad incumbent
Description

Large CRO spun out from Labcorp; competes in clinical trial services across all major therapeutic areas with central lab capabilities adjacent to REV's scope.

TypeBroad incumbent
Description

Large full-service CRO with global trial operations and biopharmaceutical services; competes for biotech clinical trial engagements REV targets.

10Veristat
TypeEmerging player
Description

Smaller specialty CRO with biostatistics, regulatory, and clinical operations focus serving emerging oncology and rare disease sponsors; comparable business profile at a smaller scale than REV.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles14 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

REV Clinical

Contract Research Organization (CRO) / Clinical Research Servicesrevclinical.com

REV Clinical is a US-based clinical CRO providing end-to-end trial design, regulatory, biometrics, and rescue services for pharmaceutical, biotech, and medtech sponsors, with operational hubs in the US, India, and Australia via its Global Velocity Network™.

What REV Clinical does

REV Clinical is a US-headquartered contract research organization (CRO) founded in 2010 as CBCC Global Research and rebranded under its current name in January 2026. The company provides end-to-end clinical trial services for pharmaceutical, biotechnology, and medical-device sponsors, organized around six solution lines: Clinical Trial Design & Operations, Regulatory & Submission Expertise, Biometrics & Data Management, the proprietary Global Velocity Network™, Quality & Compliance, and Trial Rescue Services. Therapeutic specialization covers oncology, neurology, ophthalmology, and rare disease, with claimed depth in 17+ oncology indications and experience across first-in-human through pivotal and post-market studies.

The operational backbone is the Global Velocity Network™, a tri-country site and operational footprint concentrated in the United States (Bakersfield, CA headquarters), India (Ahmedabad subsidiary, acquired in 2012 from Vibgyor Scientific Research), and Australia (Melbourne office opened May 2026). The company reports partnerships with 500+ clinical sites, access to approximately 4,000 new oncology patients annually via the affiliated CBCC Oncology Center, 50+ regulatory inspections cleared since 2021 without material findings (FDA, EMA, ANVISA, ISO, CDSCO, MOH Kazakhstan), and a Track record of 15+ trial rescue engagements with >80% of rescued trials exceeding patient-recruitment targets.

REV Clinical generates revenue through fee-for-service, project-based clinical trial contracts priced by scope, phase, therapeutic area, and geographic reach, with multi-year contract cadences. Go-to-market is direct enterprise sales led by senior leadership engagement, supplemented by participation in industry conferences (ASRS, AAO, CPHI Milan, ASH, CNS Summit) and content marketing through its Knowledge Center. The company is privately held following a 2025 partnership with Edgewater Capital Partners, and employs 200+ professionals globally (with a separate firmographic count of 51-100 reported W-2 employees).

REV Clinical firmographics

Firmographics
Name
REV Clinical
Legal name
REV Clinical
Website
https://revclinical.com
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
101–250 employees
Short description
REV Clinical is a US-based clinical CRO providing end-to-end trial design, regulatory, biometrics, and rescue services for pharmaceutical, biotech, and medtech sponsors, with operational hubs in the US, India, and Australia via its Global Velocity Network™.
Ownership category
akta.pro rank

REV Clinical industry classification

Industry
Product category
Contract Research Organization (CRO) / Clinical Research Services
NAICS
Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLAGAAAF
Clinical Data Management, Biostatistics & Statistical Programming CROs
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs

Keywords

  • Clinical research services
  • Contract research organization
  • Clinical trial management
  • Regulatory submission services
  • Biometrics data management

Where REV Clinical is headquartered

Location

Headquarters

HQ city
Bakersfield
HQ country
United States
HQ region
North America

Offices3 records

Markets served

REV Clinical business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Clinical Trial Services: REV Clinical operates as a Contract Research Organization (CRO) providing fee-for-service clinical trial services including trial design, regulatory submissions, biometrics, site management, and operational execution. Services are provided to pharmaceutical, biotech, and medtech sponsors on a project-by-project basis with pricing based on scope, phase, and geographic reach.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom project-based pricing

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

REV Clinical product offering

Product offering

Core offering

REV Clinical is a US-based Contract Research Organization (CRO) that designs, manages, and executes clinical trials for pharmaceutical, biotech, and medtech sponsors. The company provides end-to-end services including clinical trial design and operations, regulatory submissions, biometrics and data management, quality compliance, and trial rescue services. It operates a proprietary Global Velocity Network™ of strategic sites across the United States, India, and Australia, with deep therapeutic expertise in oncology, neurology, ophthalmology, and rare disease.

Product overview

REV Clinical is a US-based clinical CRO providing a comprehensive suite of integrated clinical research services organized around six core offerings: Clinical Trial Design & Operations, Regulatory & Submission Expertise, Biometrics & Data Management, the Global Velocity Network™ (strategic site network across US, India, and Australia), Quality & Compliance, and Trial Rescue Services. The company specializes in four therapeutic areas: Oncology, Neurology, Ophthalmology, and Rare Disease. The Global Velocity Network™ serves as the operational backbone connecting site networks across strategic hub regions, while Quality & Compliance underpins all services through rigorous SOPs and regulatory compliance. The Trial Rescue Services offering extends the company's value proposition to troubled trials requiring rapid intervention.

Differentiator

Problem solved

Functional benefit

Products and services

  • Clinical Trial Design & Operations

Quantifiable outcome

  • Exceeds patient recruitment targets for >80% of rescue trials
  • +2 more outcomes

Companies that use REV Clinical

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles3 records

REV Clinical technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

REV Clinical partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • CBCC Oncology CentercoreStrategic or Co-development PartnerStrategic alliance with CBCC Oncology Center in Bakersfield, California provides access to world-class clinicians, facilities, and equipment, as well as approximately 4,000 new oncology patients annually. The center provides end-to-end care including screening, biospecimen collection/testing, imaging, infusions, injections, and surgeries within a 150,000-square-foot complex staffed by over 360 specialists. This partnership accelerates enrollment in REV's oncology trials conducted in the US.

Scale indicators9 records

Recent moves9 records

Expansion highlights6 records

REV Clinical competitors and assessment

Company assessment

Direct peers

  • Medpace Holdings: Mid-sized clinical CRO with concentrated therapeutic expertise (oncology, neurology, rare disease) and a reputation for operational rigor; competes head-to-head with REV for biotech and mid-cap pharma trials.
  • Worldwide Clinical Trials: Mid-sized specialty CRO with strong neuroscience and oncology focus serving small to mid-sized biotech; closely comparable business model and target customer to REV Clinical.
  • Premier Research: Specialty CRO with deep pediatric, oncology, and rare disease focus; competes directly with REV for niche clinical trial programs from emerging biotech sponsors.
  • Clinipace Worldwide: Mid-sized full-service CRO emphasizing flexible, mid-tier biotech client engagement with therapeutic breadth including oncology; comparable customer profile and operational model to REV.

Emerging players

  • Novotech: Asia-Pacific-headquartered CRO known for biotech-focused clinical trial services across the region; relevant as a regional capability comparator for REV's Global Velocity Network including its new Australia hub.
  • Veristat: Smaller specialty CRO with biostatistics, regulatory, and clinical operations focus serving emerging oncology and rare disease sponsors; comparable business profile at a smaller scale than REV.

Broad incumbents

  • IQVIA Holdings: Largest global CRO and clinical services provider; competes broadly with REV in oncology and other therapeutic areas but at vastly greater scale and technology depth.
  • ICON plc: Top-tier global CRO with full-service clinical development capabilities; competing incumbent for the same pharma and biotech budgets as REV.
  • Labcorp Drug Development (Fortrea): Large CRO spun out from Labcorp; competes in clinical trial services across all major therapeutic areas with central lab capabilities adjacent to REV's scope.
  • Parexel International: Large full-service CRO with global trial operations and biopharmaceutical services; competes for biotech clinical trial engagements REV targets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key highlights6 records

Customer concentration

REV Clinical compliance and trust

Trust signal

Compliance6 records

REV Clinical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

REV Clinical leadership team

Management profile

Number of profiles

Profiles14 records

REV Clinical subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

REV Clinical funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

REV Clinical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about REV Clinical

What does REV Clinical do?

REV Clinical is a US-based Contract Research Organization (CRO) that designs, manages, and executes clinical trials for pharmaceutical, biotech, and medtech sponsors. The company provides end-to-end services including clinical trial design and operations, regulatory submissions, biometrics and data management, quality compliance, and trial rescue services. It operates a proprietary Global Velocity Network™ of strategic sites across the United States, India, and Australia, with deep therapeutic expertise in oncology, neurology, ophthalmology, and rare disease.

Is REV Clinical a public or private company?

REV Clinical is a private company. It is classified as private equity controlled and is currently operating.

When was REV Clinical founded?

REV Clinical was founded in 2010. It employs 101 to 250 people.

Where is REV Clinical based?

REV Clinical is headquartered in Bakersfield, United States, in the North America region.

How does REV Clinical make money?

One revenue line is on record: clinical Trial Services.

Who are REV Clinical's main competitors?

Direct peers on record are Medpace Holdings, Worldwide Clinical Trials, Premier Research and Clinipace Worldwide. Emerging players are Novotech and Veristat. Broad incumbents are IQVIA Holdings, ICON plc, Labcorp Drug Development (Fortrea) and Parexel International.

Does REV Clinical have an API?

No public API is recorded for REV Clinical.

What industry is REV Clinical in?

REV Clinical's product category is Contract Research Organization (CRO) / Clinical Research Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals